{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T01:40:17Z","timestamp":1698543617175},"reference-count":48,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3953,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[1997,9]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> Interleukin\u201012 (IL\u201012) is a heterodimeric cytokine that promotes cell\u2010mediated immunity by facilitating type 1 helper T\u2010lymphocyte responses, inducing the secretion of interferon\u2010\u03b3 from both T and natural killer cells, enhancing the lytic activity of natural killer cells, and augmenting specific cytolytic T\u2010lymphocyte responses. In addition, IL\u201012 can increase the production of some subclasses of IgG antibodies. IL\u201012 has been shown to have potent therapeutic effects in a number of animal models of tumours and infectious diseases, including several viral infections. These results have led to the initiation of clinical trials to evaluate the therapeutic potential of IL\u201012 in human cancer patients and in patients infected with the human immunodeficiency virus. The biological activities of IL\u201012 suggest that it may also have clinical utility in the treatment of patients suffering from chronic hepatitis B or Cvirus infections. Because of the lack of suitable animal models for evaluating the efficacy of IL\u201012 in the treatment of infections with these viruses, only a clinical trial in patients with chronic viral hepatitis can address the potential role of IL\u201012 as an effective treatment for these disorders.<\/jats:p>","DOI":"10.1111\/j.1365-2893.1997.tb00158.x","type":"journal-article","created":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T10:47:40Z","timestamp":1207565260000},"page":"33-39","source":"Crossref","is-referenced-by-count":16,"title":["Interleukin\u201012: potential clinical applications in the treatment of chronic viral hepatitis"],"prefix":"10.1111","volume":"4","author":[{"given":"M. K.","family":"Gately","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(88)90049-4"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6808"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.3.827"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008"},{"key":"e_1_2_1_6_2","first-page":"619","article-title":"Interleukin\u201012. Biologic activity, therapeutic utility, and role in disease","volume":"72","author":"Hendrzak JA","year":"1995","journal-title":"Lab Invest"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199600522-00005"},{"key":"e_1_2_1_8_2","first-page":"3","volume-title":"Important Advances in Oncology","author":"Brunda MJ","year":"1995"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0888-7543(05)80283-6"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.146.9.3074"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.10.4143"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.153.1.128","article-title":"Expression cloning of a human IL\u201012 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp 130","volume":"153","author":"Chua AO","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2494(96)83013-6"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8097337"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8097338"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.223"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.1.111"},{"key":"e_1_2_1_18_2","first-page":"A241","article-title":"Biological characterization of IL\u201012 p40 knockout mice","volume":"9","author":"Warrier R.","year":"1995","journal-title":"FASEB J"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.5.2444"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250329"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/7.9.1519"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.3.1253"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.901"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.4.1045"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.4049\/jimmunol.155.12.5684","article-title":"IL\u201012 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system","volume":"155","author":"Bi Z.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1128\/jvi.69.12.8147-8150.1995","article-title":"The in vivo antiviral activity of interleukin\u201012 is mediated by gamma interferon","volume":"69","author":"Ozmen L.","year":"1995","journal-title":"J Virol"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2199"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7904381"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.4049\/jimmunol.155.10.4817","article-title":"Nonviable bacterial antigens administered with IL\u201012 generate antigenspecific T cell responses and protective immunity against Listeria monocytogenes","volume":"155","author":"Miller MA","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.155.5.2525","article-title":"IL\u201012 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN\u2010\u03b3\u2010receptor\u2010deficient mice","volume":"155","author":"Schijns VECJ","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.150.10.4659"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.6.1565"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.143.8.2650","article-title":"Recognition of hepatitis B virus envelope proteins by liver\u2010infiltrating T lymphocytes in chronic HBV infection","volume":"143","author":"Barnaba V.","year":"1989","journal-title":"J Immunol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.3764"},{"key":"e_1_2_1_35_2","first-page":"187","article-title":"Interleukin\u201012: a cytokine with therapeutic potential in oncology and infectious diseases","volume":"1","author":"Gately MK","year":"1994","journal-title":"Therapeutic Immunol"},{"key":"e_1_2_1_36_2","first-page":"862","article-title":"Biologic effects of recombinant human interleukin\u201012 in squirrel monkeys (Saimiri sciurcus)","volume":"71","author":"Sarmiento UM","year":"1994","journal-title":"Lab Invest"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/6.1.157"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.154.9.4333","article-title":"Cytotoxic NK 1.1 Ag+\u03b1\u03b2 T cells with intermediate TCR induced in the liver of mice by IL\u201012","volume":"154","author":"Hashimoto W.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.15.6847"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116497"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90761-7"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.149.10.3339","article-title":"Intraheptic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis","volume":"149","author":"Koziel MJ","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2583"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.2.817"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.4823"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.907"},{"key":"e_1_2_1_47_2","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.153.11.5167","article-title":"IL\u201012 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis","volume":"153","author":"Romani L.","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_48_2","unstructured":"LavigneLM SchoopfLR ChungCL SypekJP.Effects of rmIL\u201012 onin vivocytokine responses of C57BL\/6 mice systemically infected withC. albicans.Abstracts of the 9th International Congress of Immunology San Francisco 1995p.894."},{"key":"e_1_2_1_49_2","first-page":"78","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human interleukin\u201012 in male rhesus monkeys","volume":"274","author":"Nadeau RR","year":"1995","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.1997.tb00158.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.1997.tb00158.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T11:05:38Z","timestamp":1695726338000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.1997.tb00158.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":48,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1111\/j.1365-2893.1997.tb00158.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.1997.tb00158.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}